ClinicalTrials.govpublic full text
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
breast cancer, triple negative breast cancer, stage iv breast cancer, metastatic breast cancer, triple negative breast cancer (tnbc), tigatuzumab (cs-1008), abraxane (abi-007), her-2-neu negative, er negative, pr negative, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876874
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.